With economies starting to reopen, now is the perfect time to dig for diamonds in the rough.
Helping, we have news of vaccine development.
For example, Novavax just started its first human study of its COVID-19 vaccine. Initial results on safety and immune responses due in July 2019.
“Administering our vaccine in the first participants of this clinical trial is a significant achievement, bringing us one step closer toward addressing the fundamental need for a vaccine in the fight again...
Already a member? Login below, or click here to register now for free.